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1. Introduction
  The introduction of oxyimino-cephalosporins into clinical 
practice for the treatment of resistant gram-negative 
bacterial infections was soon followed by the development 
of extended-spectrum 毬-lactamases (ESBLs). ESBLs are 
usually plasmid-encoded enzymes derived from TEM- 
and SHV- type 毬-lactamases by one or more amino acid 
substitutions which confer different levels of resistance to 
ceftazidime, cefotaxime, monobactams and to other broad-
spectrum cephalosporins[1]. The CTX-M-type enzymes, 
which are non-TEM and non-SHV derivatives, represent 
a rapidly growing family of ESBLs. CTX-M type ESBLs 
have become the most prevalent family of ESBLs among 
Enterobacteriaceae since their first report in 1986[2].
  Co-existence of class A and class C type 毬-lactamases 
in Enterobacteriaceae is frequently reported from many 
countries[3-8], however the molecular reports from India are 
fragmentary regarding the occurrence of class A and class C 
毬-lactamases; especially looking for the co-occurrence[9]. 
Therefore, the present study was planned to look for the 
occurrence of bla genes of class A ESBLs (blaCTX-M, blaTEM, 
blaSHV) and class C 毬-lactamase gene (blaampC). The isolates 
were also analyzed for the simultaneous occurrence of class 
A and class C 毬-lactamases. Moreover the comparative 
analysis in isolates obtained during year 2009 and 2010 was 
Objective: To determine the occurrence of class A and class C 毬-lactamase genes and their co-
occurrence in Indian Enterobacteriaceae. Methods: 52 third generation cephalosporin resistant 
isolates were phenotypically detected by combination disk method and screened by PCR to 
identify class A and class C type 毬-lactamase genes. Results: Of the 52 isolates, 94.2% (49) 
were found harboring any of the blaESBLs. blaCTX-M, blaSHV and blaTEM were present in 82.6% (43/52), 
59.6% (31/52), and 42.3% (22/52) isolates, respectively. Of the 49 ESBL positive isolates 57.1% 
(28/49) showed co-occurrence of blaampC with blaESBLs. On the contrary, the collection from 2009 
showed their co-occurrence in 81.4% isolates. Conclusions: The comparative study shows a 
downward trend for co-existence of blaESBLs with blaampC from 2009 to 2010. Further large scale 
studies are needed to address the co-occurrence of class A and class C 毬-lactamases in India 
and the resistance trend occurring over a period of time.
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performed to find out the frequency and trend of these bla 
genes over a period of time.
2. Material and methods
2.1. Bacterial isolates
  A total of 52 nonduplicate isolates of Enterobacteriaceae (39 
E.coli and 13 Klebsiella spp.) reported resistant to any of the 
third generation cephalosporin and obtained from various 
clinical specimens (pus, urine, sputum, cervical swab, drain 
and abdominal fluid) of inpatients and outpatients from 
JNMC&H, Aligarh Muslim University, from January 2010 to 
June 2010 were studied. Antibiotics susceptibility testing 
was performed on Mueller-Hinton agar by the standard disk 
diffusion method according to the Clinical and Laboratory 
Standards Institute (CLSI; formerly NCCLS) guidelines[10]. 
Following antibiotic disks were used cefoperazone (75 毺g), 
cefixime (5 毺g), cefotaxime (30 毺g), ceftazidime (30 毺g), 
ceftriaxone (30 毺g), cefpirome (30 毺g), cefepime (30 毺g), 
ofloxacin (5 毺g), gentamicin (10 毺g), amikacin (30 毺g), 
gatifloxacin (5 毺g) and aztreonam (30 毺g). Antibiotic disks 
were procured from HiMedia Laboratories, Ltd., India.
2.2. Phenotypic Detection of ESBL
  All isolates were screened for ESBL production by 
combination disk method using disks of cefotaxime (30 毺g) 
versus cefotaxime-clavulanate (30/10 毺g), and ceftriaxone 
(30 毺g) versus ceftriaxone-sulbactam (30/15 毺g). An increase 
in zone diameters of ≥5 mm and ≥8 mm in combination 
discs containing clavulanate and sulbactam, respectively, 
in comparison to their respective antibiotics was taken as a 
positive result for ESBL-producers[11]. 
2.3. Molecular characterization of SHV, TEM and CTX-M 
ESBLs by multiplex PCR
  All isolates were screened for the presence of geno-groups 
of CTX-M by multiplex PCR using specific primers for CTX-
M-1, -2, -8, -9 and -25/26 groups, and PCR conditions 
as described by Woodford et al[12]. These isolates were 
also characterized to determine blaTEM and blaSHV with the 
universal primer sets as described previously[13]. E. coli 
isolates (D1, D2, and D3), kindly provided by Prof. Daniel 
Jonas, Germany, and was used as positive controls for SHV, 
TEM and CTX-M-15, respectively. 
2.4. Detection of ESBL positive isolates for co-existence of 
blaampC
  All genotypically ESBL positive isolates were characterized 
for the co-existence of blaampC using method as given 
by Feria et al[14] with some modification as described 
previously[13].
2.5. Comparative analysis
  A subset of 76 isolates of Enterobacteriaceae collected 
during 2009 and previously characterized for class A ESBLs 
(CTX-M, TEM, SHV) was included for comparable study 
with the collection of 2010 for occurrence of blaCTX-M, blaSHV, 
and blaTEM and also to determine the co-existence of these 
blaESBLs with blaampC. 
2.6. Screening of PCR results
  After amplification, PCR products were analyzed in 2% 
agarose gel in 1伊 TAE buffer and for staining ethidium 
bromide (EtBr) at 0.1 毺L/mL was used as nucleic acid 
intercalating agent for the visualization of amplified products 
under an UV light. High range DNA rular (Genei) was used 
to determine the size of DNA products.
3. Results
3.1. Antibiotic resistance
  All 52 isolates included in the study were found resistant 
to cefotaxime, cefoperazone and aztreonam. The detailed 
results for antibiotics resistance rates are given in Table 1. 
100% resistance was found with the following antibiotics 
cefoperazone, cefotaxime and aztreonam.
 
3.2. Phenotypic ESBL detection
  Phenotypically, 80.4% and 86.5% isolates were found 
as ESBL producers by combination disk method using 
cefotaxime/cefotaxime-clavulanate and ceftriaxone/
ceftriaxone-sulbactam, respectively.
3.3. Identification of SHV, TEM and CTX-M-genogroups by 
PCR
  Out of 52 isolates, 49 (94.2%) were found positive for ESBL 
Table 1
Antibiotic resistance rates of Enterobacteriaceae isolates (n=52).
Antibiotics used % Resistance (n)
Cefoperazone 100.0 (52)
Cefixime   67.3 (35)
Cefotaxime 100.0 (52)
Ceftazidime   92.3 (48)
Ceftriaxone   92.3 (48)
Cefepime   57.6 (30)
Cefpirome   42.3 (22)
Ofloxacin   28.8 (15)
Gentamicin   63.4 (33)
Amikacin   53.8 (28)
Gatifloxacin   94.2 (49)
Aztreonam 100.0 (52)
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genes, PCR assays revealed the occurrence of blaCTX-M, blaSHV 
and blaTEM in 82.6% (43/52), 59.6% (31/52), and 42.3% (22/52) 
isolates, respectively. Of the 49 ESBL positive isolates, 
30.6% (15/49), 4% (2/49), and 4% (2/49) isolates were found 
harboring single bla genes viz. blaCTX-M, blaSHV and blaTEM, 
respectively. Co-occurrence of bla genes was also noticed; 
co-occurrence of blaCTX-M with each of blaSHV, blaTEM and 
with both blaSHV + blaTEM was noticed in 20.4% (10), 2% (1) 
and 34.6% (17) isolates, respectively. CTX-M groups were 
characterized by multiplex PCR which indicated that all the 
isolates carry gene for CTX-M-genogroup-1 (Figure 1). 
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Figure 1. 2% Agarose gel is showing positive isolates of CTX-M type 
gene (Lane 4-11) of 415 bp with positive control strain D3 (E. coli) in 
lane 2 and negative control in lane 3, while lane 12-14 shows negative 
isolates, lane 1 and 15 are showing Genei High range DNA ruler.
3.4. Co-existence of blaESBLs with blaampC
  Out of 49 isolates (collected during 2010) harboring blaESBLs 
57.1% (28/49) showed co-existence for blaampC (Figure 2). 
In the collection of 76 isolates of 2009, 70 isolates were 
harboring blaESBLs. Of these 70 isolates harboring blaESBLs, 
81.4% (57/70) showed co-existence of blaampC with blaESBLs.
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Figure 2. 2% Agarose gel is showing positive isolates of ampC type 
gene (Lane 4-11) of 634 bp with positive control strain D1 (Citrobacter 
spp.) in lane 2 and negative control in lane 3, while lane 12-14 shows 
negative isolates, lane 1 and 15 are showing Genei High range DNA 
ruler.
3.5. Comparative analysis of collections of year 2009 and 
year 2010
  On comparison of genotypic results of two year’s 
collections (2009 and 2010), we found nearly similar 
occurrence for blaESBLs; 94.2% (70/76) and 92.1% (49/52) in 
respective years, 2009 and 2010. In 2010, 82.6% (43/52), 
59.6% (31/52), and 42.3% (22/52) isolates were found positive 
for blaCTX-M, blaSHV, and blaTEM, respectively, while in 2009 
these bla genes were present in 88.1% (67/76), 43.4% (33/76), 
43.4% (33/76) isolates, respectively. On analyses of various 
combinations like blaCTX-M, blaCTX-M+blaSHV, blaCTX-M+blaTEM, 
blaCTX-M+blaSHV+blaTEM and blaSHV+blaTEM in 2010, we found 
these occurrences in 30.6% (15/49), 20.4% (10/49), 2% (1/49), 
34.6% (17/49) and 4% (2/49) isolates, respectively, while 
in 2009 these combinations were present in 31.4% (22/70), 
18.5% (13/70), 20% (14/70), and 25.7% (18/70), respectively; 
however the combination of blaSHV+blaTEM was absent in this 
collection of year 2009. By PCR, in all isolates harboring 
blaESBLs, blaampC was detected in 81.4% (57/70) and 57.1% 
(28/49) isolates from collections of year 2009 and 2010, 
respectively. In 2010, co-existence of blaampC was noticed 
in 46.6% (7/15), 50% (5/10), 100% (1/1), 76.4% (13/17), and 
100% (2/2) isolates having different combinations of blaCTX-M, 
blaCTX-M+blaSHV, blaCTX-M+blaTEM, blaCTX-M+blaSHV+blaTEM and 
blaSHV+blaTEM, respectively. While in 2009, the co-existence 
of blaampC with the combinations of blaCTX-M, blaCTX-M+blaSHV, 
blaCTX-M+bla TEM,  blaCTX-M+bla SHV+bla TEM was found in 
86.3%(19/22), 92.3%(12/13), 85.7%(12/14), 72.2%(13/18) of 
isolates, respectively. In 2009 out of two isolates harbouring 
only blaSHV, one was found positive for co-existence of 
blaampC.
4. Discussion
  Nowadays, CTX-M type 毬-lactamases had become 
the principal cause of resistance to third-generation 
cephalosporins in Enterobacteriaceae worldwide[15]. In the 
present study, a collection of 52 isolates was characterized 
for ESBLs, which showed 94.2% (49/52) isolates carrying 
blaESBLs. In the previous collection of 2009 we also found 
comparatively similar percentage of isolates (92.1%) for 
the presence of blaESBLs. A previous report from south India 
in 2006[16] showed 35.89% prevalence for blaCTX-M gene 
while in present study we observed a noteworthy increase 
82.6% (43/52), which is inflexible in comparison to some 
recent reports from Ireland (89%), China (89%), Spain 
(86%), France (83%) and UK (85.2%)[17-21]. Since the first 
description of blaCTX-M-15 in India[22], it is now considered a 
dominant type with some exceptions worldwide[15,23]. On 
Anuradha Singh et al./Asian Pacific Journal of Tropical Medicine (2011)764-768 767
reviewing the literature of Indian studies we found only CTX-M 
group-1 as the dominant genogroup of CTX-M[13,24-26].
  CTX-M-type extended spectrum 毬-lactamases (ESBLs) 
and AmpC-type 毬-lactamases have been found as two 
major contributors in recent years[1,2,27,28]. Reports of 
multiple 毬-lactamases in a single pathogen are increasing 
for Enterobacteriaceae[3,5-8,13]. CMY-2 type was found to be 
associated with CTX-M-14 in a Parisian E. coli isolate[4]. In 
Taiwan, CTX-M and SHV-type ESBLs with CMY- and DHA- 
type AmpC enzymes are the most common毬-lactamases that 
conferred resistance to extended-spectrum cephalosporins 
in clinical K. pneumoniae isolates[6,29]. The emergence 
of a multidrug resistant K. pneumoniae isolate, which 
produces VIM-4, CTX-M-15, TEM-1, CMY-4 have been 
reported from France[30]. Co-existence of CMY-8 and CTX-
M-3 was reported in a 269 kb conjugative plasmid from K. 
pneumoniae[31]. A recent report for co-existence of CMY-6 
and CTX-M-15 has recently been reported on the similar 
type of plasmid from India[9]. 
  These studies provided us to find out the co-existence 
of multiple genes of 毬-lactamases of two major classes, 
class A and class C in our isolates. So, a collection of 52 
isolates obtained during 2010 and a previously characterized 
subset of 76 isolates (2009) were characterized to determine 
the frequency of co-existance of different combinations 
of blaESBLs with blaampC. In the present collection of 2010, 
among the blaESBLs harboring isolates (n=49), we found that 
highest number of isolates i.e. 34.6% (17) were positive 
for combination of blaCTX-M+ blaSHV+ blaTEM while least 
number (2%) was positive for combination of blaCTX-M+ 
blaTEM. Out of 49 ESBL positive isolates, co-existence of bla 
genes with blaampC was present in 57.1% (28/49) isolates 
of Enterobacteriaceae. We looked co-existence of ampC, 
and found 46.6% (7/15), 50% (5/10), 100% (1/1), 76.4% 
(13/17), and 100% (2/2) of isolates positive for co-existence 
in different combinations of blaCTX-M, blaCTX-M+blaSHV, 
blaCTX-M+blaTEM, blaCTX-M+blaSHV+blaTEM and blaSHV+blaTEM, 
respectively, while in 2009 collection co-existence of 
blaampC occurred in 86.3%(19/22), 92.3%(12/13), 85.7%(12/14), 
72.2%(13/18) isolates in different combinations of blaCTX-M, 
blaCTX-M+blaSHV, blaCTX-M+blaTEM, blaCTX-M+blaSHV+blaTEM, 
respectively. 
  In the present collection we could not find any positivity 
for co-existence of blaampC in those isolates which harbor 
only single gene of SHV or TEM, because of small sample 
size, but in our previous collection of 2009 one isolate was 
found positive for co-existence of blaSHV and blaampC. On 
comparison of both collections of year 2009 and 2010, in 2009 
we observed 81.4% (57/70) isolates positive for co-existence 
of bla genes with blaampC, while in the collection of 2010, we 
found co-existence only in 57.1% (28/49) isolates, and that 
indicates that the implementation of antibiotic prescription 
policies in our institution is moving on a right track. 
However further large scale studies are needed to address 
the trend of occurrence of bla genes over a period of time.
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